Your browser is no longer supported. Please, upgrade your browser.
Settings
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E23.49 EPS (ttm)5.43 Insider Own0.06% Shs Outstand2.74B Perf Week-2.21%
Market Cap349.74B Forward P/E14.90 EPS next Y8.56 Insider Trans-9.19% Shs Float2.68B Perf Month-2.79%
Income14.90B PEG2.97 EPS next Q2.01 Inst Own68.50% Short Float0.65% Perf Quarter-13.18%
Sales76.45B P/S4.57 EPS this Y-8.50% Inst Trans0.14% Short Ratio2.13 Perf Half Y-9.40%
Book/sh21.94 P/B5.81 EPS next Y5.67% ROA0.90% Target Price149.48 Perf Year5.09%
Cash/sh6.67 P/C19.12 EPS next 5Y7.91% ROE1.90% 52W Range121.11 - 148.32 Perf YTD-8.71%
Dividend3.36 P/FCF39.59 EPS past 5Y7.10% ROI15.70% 52W High-14.00% Beta0.73
Dividend %2.63% Quick Ratio1.10 Sales past 5Y2.60% Gross Margin67.00% 52W Low5.32% ATR2.67
Employees134000 Current Ratio1.40 Sales Q/Q11.50% Oper. Margin23.10% RSI (14)44.30 Volatility1.73% 2.07%
OptionableYes Debt/Eq0.57 EPS Q/Q-23.60% Profit Margin1.70% Rel Volume0.72 Prev Close127.72
ShortableYes LT Debt/Eq0.51 EarningsApr 17 BMO Payout603.10% Avg Volume8.23M Price127.55
Recom2.40 SMA20-0.99% SMA50-1.93% SMA200-5.71% Volume5,889,976 Change-0.13%
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Jul-21-17Downgrade Alembic Global Advisors Neutral → Underweight
Jul-20-17Resumed Credit Suisse Outperform $148
Jul-05-17Reiterated Morgan Stanley Overweight $135 → $140
May-18-17Reiterated Stifel Hold $124 → $128
May-15-17Upgrade JP Morgan Neutral → Overweight
Jan-26-17Downgrade Wells Fargo Outperform → Market Perform
Jan-25-17Reiterated RBC Capital Mkts Outperform $133 → $128
Apr-19-18 07:52PM  P&G, GE and IBM Need to Innovate; Has Starbucks' Stock Grown Ice Cold?--ICYMI TheStreet.com
03:26PM  Healthcare ETFs in Focus After Johnson & Johnson Q1 Earnings Zacks
Apr-18-18 09:00PM  3 Drugs That Are Moving the Needle at Johnson & Johnson Motley Fool
06:11PM  After the Bell: Dow Drops 38 Points BecauseIBM Barrons.com
05:10PM  Kentucky Gov. Matt Bevin slams state AG's lawsuit against J&J: 'These are political moves' CNBC
01:23PM  Kentucky Governor Bevin: I'm not on board with JNJ opioid... CNBC Videos
11:24AM  Kentucky accuses J&J of contributing to opioid epidemic Reuters
11:07AM  IBM and J&J stocks cut 100 points from Dow industrials in early trading MarketWatch
10:50AM  Kentucky accuses J&J of contributing to opioid epidemic Reuters
09:11AM  Location revealed: Johnson & Johnson institute's new HQ to go in Lake Nona's Medical City American City Business Journals
07:00AM  The resume of the future will tell employers who you are, and not just what youve done Quartz
12:17AM  [$$] Johnson & Johnson Raises Sales Outlook The Wall Street Journal
Apr-17-18 07:37PM  Trump touts economy as stocks rally Fox Business Videos
05:01PM  U.S. drug agency proposes rules to rein in opioid manufacturing Reuters
05:00PM  What to Look for as First-Quarter Earnings Hit Around the Globe Bloomberg
04:47PM  UnitedHealth and Alphabet climb; Tesla and Comerica skid Associated Press
04:44PM  Wall Street rises on earnings hopes, Netflix soars Reuters
04:26PM  J&J Boosts Sales Forecast On Growing Demand For Cancer Drugs Investor's Business Daily
04:08PM  Dow Jumps Over 200 Points; S&P 500 and Nasdaq Also Finish Higher TheStreet.com
01:12PM  J&J raises sales forecast but keeps profit outlook unchanged; shares drop Reuters
01:08PM  Drug Division Drives Johnson & Johnson Morningstar
01:07PM  Why Geron Corporation's Stock Is Heading Higher Today Motley Fool
12:43PM  Johnson & Johnson Stock Dips Despite Q1 Earnings Beat InvestorPlace
11:35AM  Johnson & Johnson (JNJ) Q1 2018 Earnings Conference Call Transcript Motley Fool
11:25AM  J&J raises sales forecast but keeps profit outlook unchanged; shares drop Reuters
11:02AM  Johnson & Johnson tops 1Q views on sales spike, but net dips Associated Press
10:45AM  J&J Lives Up to Its Valuation -- For Now Bloomberg
10:39AM  New Construction Data, Q1 Earnings In Focus Zacks
10:28AM  [$$] Johnson & Johnson Raises Sales Outlook The Wall Street Journal
10:25AM  Tax Day Not So Taxing (for Corporations, Housing) Zacks
09:40AM  J&J (JNJ) Tops Q1 Earnings Estimates, Raises Sales Guidance Zacks
09:40AM  Zytiga, Stelara Lift Johnson & Johnson's Sales Motley Fool
09:38AM  Stocks to Watch: Goldman Sachs, Netflix, Amazon, Tesla, Microsoft, Roku, UnitedHealth, J&J, Walmart The Wall Street Journal
09:11AM  Morning Movers: Goldman, UnitedHealth Jump on Earnings, Twitter Takes Off on Upgrade Barrons.com
09:04AM  J&J raises sales forecast on strong demand for cancer drugs Reuters
09:00AM  Premarket Trading: Blue Chips, Netflix Power Up; China Adds Tariffs Investor's Business Daily
08:53AM  [$$] US stock futures higher as earning season picks up pace Financial Times
08:37AM  Why Johnson & Johnsons (NYSE:JNJ) ROE Of 2.16% Does Not Tell The Whole Story Simply Wall St.
08:06AM  Stocks making the biggest moves premarket: UNH, JNJ, GS, NFLX, ROKU, DIS & more CNBC
07:52AM  Johnson & Johnson CFO Plans for a Strong Year for 2018 Bloomberg Video
07:52AM  Johnson & Johnson CFO Plans for a Strong Year for 2018 Bloomberg
07:49AM  Global stocks turn higher on upbeat corporate earnings Associated Press
07:35AM  New Research: Key Drivers of Growth for Johnson & Johnson, Chesapeake Energy, Visa, Celgene, Adobe, and Markel Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
07:32AM  [$$] Johnson & Johnson up in pre-market as Q1 results top forecasts Financial Times
07:07AM  J&J Raises Sales Forecast in Health Earnings Season Kick-Off Bloomberg
06:56AM  Johnson & Johnson's stock gains after profit and revenue beat, raised outlook MarketWatch
06:50AM  Johnson & Johnson CFO: Pharma business continues 'stellar... CNBC Videos
06:40AM  Johnson & Johnson Reports 2018 First-Quarter Results: PR Newswire
06:32AM  Pharma fuels Johnson & Johnson's first-quarter earnings beat CNBC
06:32AM  Here's what to expect from Johnson & Johnson earnings CNBC
06:30AM  Johnson & Johnson to Host Earnings Call ACCESSWIRE
Apr-16-18 07:35PM  Fed speakers and earnings from Goldman Sachs and others could influence Tuesday's market CNBC
04:00PM  Pa., N.J. health systems and universities form multistate clinical trials consortium American City Business Journals
01:09PM  Upcoming Earnings: Johnson & Johnson And IBM Are Scheduled To Report This Week Benzinga
10:32AM  J&J Baby Powder litigation takes new focus with asbestos claims Reuters
07:00AM  Medtronic's Portfolio Is Unmatched Morningstar
02:21AM  J&J Baby Powder litigation takes new focus with asbestos claims Reuters
01:08AM  J&J Baby Powder litigation takes new focus with asbestos claims Reuters
Apr-15-18 01:17PM  Is bluebird bio, Inc. a Buy on the Dip? Motley Fool
10:05AM  3 Things to Watch in the Stock Market This Week Motley Fool
06:31AM  Better Buy: Eli Lilly and Company vs. Johnson & Johnson Motley Fool
Apr-14-18 10:21PM  [$$] US bank earnings, World Bank-IMF spring meetings Financial Times
02:16PM  3 Top Dividend Stocks to Buy in April Motley Fool
07:17AM  3 Safe Dividend Stocks for a Chaotic Market Motley Fool
Apr-13-18 01:56PM  Local experts talks artificial intelligence on the First Coast American City Business Journals
01:30PM  10 Best Stocks to Buy and Hold Forever InvestorPlace
11:13AM  Here's Why Geron Stock Surged More Than 90% in 6 Months Zacks
11:04AM  Is J&J's (JNJ) Pharma Segment Likely to Drive Q1 Earnings? Zacks
10:31AM  Chardan: Assembly Biosciences Hep B Antiviral Data 'Positive,' But Undifferentiated From Competitor Johnson & Johnson Benzinga
10:15AM  With A -92.14% Earnings Drop, Did Johnson & Johnson (NYSE:JNJ) Really Underperform? Simply Wall St.
08:15AM  Can Johnson & Johnson Get Its Mojo Back? Motley Fool
07:48AM  Why Geron Corporation Stock Popped 84% in March Motley Fool
Apr-12-18 05:51PM  U.S. Senator Cory Booker Criticizes Pharma Companies in New Tax Report TheStreet.com
01:58PM  Top ETF Picks for Your IRA Zacks
12:30PM  Why Geron Corporation Stock Is on the Rise Today Motley Fool
12:27PM  Get a look at Johnson & Johnson's HQ expansion in Lake Nona (RENDERINGS) American City Business Journals
08:17AM  J&J (JNJ) to Begin Pharma Q1 Earnings: What's in Store? Zacks
05:19AM  Ad Prices On Fox's 'The Ingraham Angle' Fall In The Wake Of Advertiser Boycott Forbes
Apr-11-18 05:00PM  J&J, Imerys unit must pay $117 million in New Jersey asbestos cancer case Reuters
04:42PM  J&J, Imerys unit must pay $117 mln in N.J. asbestos cancer case Reuters
02:58PM  Asbestos in Talc Products Verdict Means J&J, Imerys Owe Millions Bloomberg
02:55PM  J&J, Imerys must pay $80 mln punitive damages in case linking cancer to asbestos in talc Reuters
09:37AM  Alkermes Has Some Decisions to Make Motley Fool
08:10AM  4 Blue-Chip Stocks to Buy Ahead of Eye-Popping Earnings Zacks
12:00AM  [$$] Healthcare: Cancer breakthrough leads Chinas biotech boom Financial Times
Apr-10-18 02:56PM  Why J&Js Fallen Stock Is Still Too Pricey Investopedia
11:13AM  Google to power Georgia data center with solar energy American City Business Journals
07:40AM  Wired News Johnson & Johnson to Pay Compensatory Damages over Claims Linking Cancer to Asbestos in Talc ACCESSWIRE
07:34AM  Novartis and Other Drug Stocks With FDA Catalysts in April Zacks
Apr-09-18 07:09PM  Billionaire Ken Fishers Favorite Dividend Stocks Insider Monkey
03:43PM  Glancy Prongay & Murray LLP Reminds Investors of the April 9, 2018 Deadline in the Class Action Lawsuit Against Johnson & Johnson Business Wire
11:20AM  DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Johnson & Johnson And Reminds Investors To Contact The Firm ACCESSWIRE
11:11AM  DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders of Johnson & Johnson of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 9, 2018 JNJ ACCESSWIRE
06:00AM  3 Reasons This Clinical-Stage Biotech Is an Incredible Bargain Motley Fool
Apr-06-18 03:14PM  NJ Man Wins $37 Million in J&J Baby Powder Case InvestorPlace
02:24PM  Stocks dive as US proposes more China tariffs; Dow falls 620 Associated Press
11:29AM  APRIL 9 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Johnson & Johnson And Reminds Investors To Contact The Firm ACCESSWIRE
10:36AM  MARKETS: Watch out for the 'Kudlow Put' round 2 and the Chinese tariff tantrum Yahoo Finance Video
09:59AM  The Top 5 Johnson & Johnson Shareholders (JNJ) Investopedia
09:27AM  4 Drug/Biotech Stocks to Buy Ahead of World Health Day Zacks
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. Its Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads under the STAYFREE and CAREFREE brands, and tampons under the o.b. brand; wound care products comprising adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The company's Pharmaceutical segment offers various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, cardiovascular and metabolic, and pulmonary hypertension diseases. Its Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products that include blood glucose monitoring; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Option Exercise90.44155,34214,049,130357,906Feb 20 07:46 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Sale129.86155,34220,172,401202,564Feb 20 07:46 PM
Caruso Dominic JExec VP, Finance; CFOFeb 09Option Exercise0.0010,6010154,703Feb 13 06:54 PM
Duato JoaquinExec VP, WW Chair, PharmaFeb 09Option Exercise0.009,812078,348Feb 13 06:54 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 09Option Exercise0.005,830069,992Feb 13 06:54 PM
Gorsky AlexChairman, CEOFeb 09Option Exercise0.0033,1650285,990Feb 13 06:54 PM
PETERSON SANDRA EExec VP, Group WW ChairmanFeb 09Option Exercise0.0011,445070,205Feb 13 06:54 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 09Option Exercise0.0013,2520181,655Feb 13 06:55 PM
Ullmann Michael HExec VP, General CounselFeb 09Option Exercise0.005,9530115,257Feb 13 06:55 PM
Kapusta Ronald AController, CAOFeb 09Option Exercise0.002,702032,666Feb 13 06:55 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 02Option Exercise0.0032,688032,688Feb 06 04:21 PM
Stoffels PaulusExec VP, Chief Scientific OffOct 31Option Exercise0.0075,4920203,142Nov 02 05:01 PM
Stoffels PaulusExec VP, Chief Scientific OffJul 24Option Exercise72.54102,6927,449,278230,342Jul 26 11:49 AM
Stoffels PaulusExec VP, Chief Scientific OffJul 24Sale133.14102,69213,672,629127,650Jul 26 11:49 AM
Caruso Dominic JExec VP, Finance; CFOJul 20Option Exercise61.7582,5915,099,994226,693Jul 24 11:06 AM
Caruso Dominic JExec VP, Finance; CFOJul 20Sale136.7282,59111,291,478144,102Jul 24 11:06 AM